Header links
Intranet
Donate now
image/svg+xml Map
Contact us

17/02/2025

Jornada 'New technologies and methods in immunogenetics'
Ubicació
Sala d’actes de la planta 10 de l’Hospital General
Etiqueta
Jornades
21/01/2025

Vall d'Hebron Talks by VHIR 'In vitro evolution of nucleic acids: from the origin of life to its biomedical applications'
Ubicació
Sala d'actes de l'Edifici Central del VHIR (Planta 0)
Etiqueta
Vall d'Hebron Talks by VHIR
18/12/2024

Assajos clínics per a les persones: inclusivitat, igualtat i equitat
Ubicació
Sala d’actes de la planta 10 de l’Hospital General
Etiqueta
Jornades
17/12/2024

Vall d'Hebron Talks by VHIR 'Understanding the Bidirectional Communication Between the Brain and the Immune System in Stroke'
Ubicació
Sala d’actes de la planta baixa de l’Hospital General
Etiqueta
Vall d'Hebron Talks by VHIR
20/01/2025

Vall d'Hebron Talks by VHIR 'Supervivència al càncer de mama. Perspectiva de la pròpia dona supervivent'
Etiqueta
Vall d'Hebron Talks by VHIR
12/12/2024

Retiment de Comptes VHIR
Ubicació
Sala d'actes de l'Edifici Central del VHIR (Planta 0)
Etiqueta
Jornades

Ajuts per a la intensificació de professionals de la salut adscrits a la Direcció d'Infermeria

Estudio de fase III para evaluar la eficacia y la seguridad de pegozafermina en sujetos con cirrosis compensada debido a esteatohepatitis asociada a disfunción metabólica (MASH)

Contact

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

LIGHTBEAM-U01 Subestudio 01A: Subestudio de fase 1//2 para evaluar la seguridad y la eficacia de zilovertamab vedotina en participantes pediátricos y adultos jóvenes con neoplasias malignas hematológicas o tumores sólidos

Contact

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio aleatorizado, doble ciego y controlado conplacebo para evaluar la eficacia y seguridad deTAK-861 para el tratamiento de la narcolepsia concataplejía (narcolepsia tipo 1)

Contact
  • Protocol code: TAK-861-3002
  • EudraCT code: No aplica
  • Pathology: Malalties del sistema respiratori
  • Principal investigator:  Romero Santo-Tomas, Odile
  • Research group:  Pneumologia
  • Service: Neurofisiologia
  • Phase: Fase III
  • Recruiting: Open
  • Status: Tancat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
Subscribe to